免疫学-话题@MedSci

#免疫学#

70篇内容 | 1061人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1889451, encodeId=c25418894511f, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Front Immunol：HIV阴性免疫活性隐球菌脑膜炎患者感染后炎症反应综合征的免疫学预测指标, objectType=article, longId=730152, objectId=3311e30152ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3311e30152ab, replyNumber=0, likeNumber=34, createdTime=2023-03-08, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3311e30152ab, moduleTitle=Front Immunol：HIV阴性免疫活性隐球菌脑膜炎患者感染后炎症反应综合征的免疫学预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3311e30152ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889450, encodeId=df96188945059, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature子刊：海军军医大学胡适/雷长海团队构建能同时识别超过十万个潜在靶点的合成免疫学治疗方法, objectType=article, longId=728901, objectId=65fae28901b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65fae28901b6, replyNumber=0, likeNumber=26, createdTime=2022-10-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65fae28901b6, moduleTitle=Nature子刊：海军军医大学胡适/雷长海团队构建能同时识别超过十万个潜在靶点的合成免疫学治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65fae28901b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889447, encodeId=e5d5188944efd, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, objectType=article, longId=220575, objectId=ad652205e545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad652205e545, replyNumber=0, likeNumber=22, createdTime=2022-06-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad652205e545, moduleTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad652205e545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889452, encodeId=e27518894522e, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Front Immunol：HIV感染儿童队列中早期治疗的临床特征、病毒学和免疫学亚表型, objectType=article, longId=730155, objectId=d891e30155d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d891e30155d6, replyNumber=0, likeNumber=26, createdTime=2022-10-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d891e30155d6, moduleTitle=Front Immunol：HIV感染儿童队列中早期治疗的临床特征、病毒学和免疫学亚表型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d891e30155d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889453, encodeId=e40f188945380, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, objectType=article, longId=730662, objectId=e010e3066291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e010e3066291, replyNumber=0, likeNumber=23, createdTime=2022-09-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e010e3066291, moduleTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e010e3066291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889448, encodeId=9b111889448c7, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=J Immunother Cancer：浙大黄建团队提出三阴性乳腺癌肺转移免疫学新机制及其干预策略, objectType=article, longId=265021, objectId=bd0926502166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd0926502166, replyNumber=0, likeNumber=24, createdTime=2022-08-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd0926502166, moduleTitle=J Immunother Cancer：浙大黄建团队提出三阴性乳腺癌肺转移免疫学新机制及其干预策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd0926502166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889446, encodeId=88c51889446a2, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=免疫学期刊推荐：EUR J INFLAMM/European Journal of Inflammation, objectType=article, longId=218028, objectId=610c218028e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=610c218028e4, replyNumber=0, likeNumber=17, createdTime=2022-01-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=610c218028e4, moduleTitle=免疫学期刊推荐：EUR J INFLAMM/European Journal of Inflammation, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=610c218028e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889449, encodeId=cd5b188944989, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果, objectType=article, longId=293604, objectId=1af629360491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1af629360491, replyNumber=0, likeNumber=30, createdTime=2022-03-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1af629360491, moduleTitle=Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1af629360491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889445, encodeId=e8de188944502, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=medRxiv：新冠疫苗接种产生的中和抗体与其免疫学保护作用有关吗？, objectType=article, longId=214850, objectId=7c672148509a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c672148509a, replyNumber=0, likeNumber=22, createdTime=2022-02-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c672148509a, moduleTitle=medRxiv：新冠疫苗接种产生的中和抗体与其免疫学保护作用有关吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c672148509a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889441, encodeId=7980188944162, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究, objectType=article, longId=204791, objectId=f01d204e91a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f01d204e91a8, replyNumber=0, likeNumber=0, createdTime=2021-10-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f01d204e91a8, moduleTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f01d204e91a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889442, encodeId=72681889442c8, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=我国科学家研究联盟揭示新冠肺炎免疫学特征, objectType=article, longId=206993, objectId=117220699344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=117220699344, replyNumber=0, likeNumber=30, createdTime=2021-05-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=117220699344, moduleTitle=我国科学家研究联盟揭示新冠肺炎免疫学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=117220699344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889443, encodeId=525018894438d, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制, objectType=article, longId=209096, objectId=ca1f2090962d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1f2090962d, replyNumber=0, likeNumber=25, createdTime=2021-06-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1f2090962d, moduleTitle=Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1f2090962d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889440, encodeId=0782188944054, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=2019年全球免疫学领域销售额TOP20的制药公司, objectType=article, longId=203208, objectId=fc1c203208e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc1c203208e3, replyNumber=0, likeNumber=0, createdTime=2021-10-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc1c203208e3, moduleTitle=2019年全球免疫学领域销售额TOP20的制药公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc1c203208e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889439, encodeId=cdff1889439ff, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature Cancer: 肿瘤治疗加重COVID-19病情？——总结疫情下的肿瘤免疫学挑战, objectType=article, longId=202295, objectId=d22d2022951d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d22d2022951d, replyNumber=0, likeNumber=31, createdTime=2021-05-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d22d2022951d, moduleTitle=Nature Cancer: 肿瘤治疗加重COVID-19病情？——总结疫情下的肿瘤免疫学挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d22d2022951d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889444, encodeId=5ebb18894445b, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=免疫学 FRONT CELL INFECT MI 期刊投稿经验, objectType=article, longId=211365, objectId=2da42113652d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da42113652d, replyNumber=0, likeNumber=19, createdTime=2021-08-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da42113652d, moduleTitle=免疫学 FRONT CELL INFECT MI 期刊投稿经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da42113652d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889437, encodeId=1179188943e4f, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , objectType=article, longId=200504, objectId=f82c200504b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f82c200504b9, replyNumber=0, likeNumber=25, createdTime=2021-01-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f82c200504b9, moduleTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f82c200504b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889433, encodeId=0657188943324, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=打造免疫学细胞研究”全链条”，推动“流式平台”与“单细胞平台”高效对接, objectType=article, longId=199019, objectId=581619901989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=581619901989, replyNumber=0, likeNumber=0, createdTime=2021-05-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=581619901989, moduleTitle=打造免疫学细胞研究”全链条”，推动“流式平台”与“单细胞平台”高效对接, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=581619901989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889431, encodeId=65881889431d6, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=免疫学靶点在新冠病毒治疗中的研究进展综述, objectType=article, longId=190869, objectId=76041908691a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76041908691a, replyNumber=0, likeNumber=25, createdTime=2020-07-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76041908691a, moduleTitle=免疫学靶点在新冠病毒治疗中的研究进展综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76041908691a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889436, encodeId=ff011889436c8, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature：COVID-19的性别差异具有免疫学基础, objectType=article, longId=200263, objectId=091d20026391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091d20026391, replyNumber=0, likeNumber=21, createdTime=2021-04-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091d20026391, moduleTitle=Nature：COVID-19的性别差异具有免疫学基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091d20026391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889438, encodeId=ddb618894384c, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=J Periodontal Res：Tregs参与了牙周炎的骨免疫学机制，有利于临床治疗决策的制定, objectType=article, longId=201615, objectId=601f201615f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=601f201615f3, replyNumber=0, likeNumber=25, createdTime=2020-10-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=601f201615f3, moduleTitle=J Periodontal Res：Tregs参与了牙周炎的骨免疫学机制，有利于临床治疗决策的制定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=601f201615f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

医者仁心 (审核中...)

前往app查看评论内容

#免疫学#

Front Immunol：HIV阴性免疫活性隐球菌脑膜炎患者感染后炎症反应综合征的免疫学预测指标

2023-03-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Nature子刊：海军军医大学胡适/雷长海团队构建能同时识别超过十万个潜在靶点的合成免疫学治疗方法

2022-10-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据

2022-06-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Front Immunol：HIV感染儿童队列中早期治疗的临床特征、病毒学和免疫学亚表型

2022-10-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性

2022-09-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

J Immunother Cancer：浙大黄建团队提出三阴性乳腺癌肺转移免疫学新机制及其干预策略

2022-08-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

免疫学期刊推荐：EUR J INFLAMM/European Journal of Inflammation

2022-01-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果

2022-03-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

medRxiv：新冠疫苗接种产生的中和抗体与其免疫学保护作用有关吗？

2022-02-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究

2021-10-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

我国科学家研究联盟揭示新冠肺炎免疫学特征

2021-05-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制

2021-06-29

xiaoyeshuang (审核中...)